IP Library Patent Application 10517219
Patent Application
App. No. 10/517,219

Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/517,219
Abstract

The invention relates to the use of Ginkgo biloba extracts and, in particular, Ginkgo biloba extracts comprising between 20 and 30% flavoneglycosides, between 2.5 and 4.5% in total of ginkgolides A, B, C and J, between 2 and 4% bilobalide, less than 10% proanthocyanidins and less than 10 ppm alkylphenol-type compounds, in order to prepare a medicament that is intended to promote muscle mass to the detriment of fatty mass in patients looking to loose or gain weight by means of a diet and/or medical treatment.

Claims (27)

1 . (canceled)

2 . The method of claim 11 , wherein the flavoneglycosides and/or the ginkgolide or ginkgolides are present at least at a level of 25% by weight in the Ginkgo biloba extract.

3 . The method of claim 11 , wherein the Ginkgo biloba extract comprises from 20 to 30% of flavoneglycosides, from 2.5 to 4.5% in total of ginkgolides A, B, C and J, from 2 to 4% of bilobalide, less than 10% of proanthocyanidines and less than 10 ppm of compounds of alkylphenol type.

4 . The method of claim 3 , wherein at least one part of the ginkgolides A, B, C and J is replaced with the compounds of the formula

wherein W, X, Y and Z are independently selected from the group consisting of H, OH, alkoxy and —O-G S radicals, G S -OH being a mono- or a disaccharide, or one of their derivatives or analogues,

it being understood that at least one of W, X, Y or Z is —O-G S .

5 . The method of claim 4 , wherein the compounds of formula (I) are such that X is —OH or —O-G S , G S -OH being a mono- or a disaccharide, or one of their derivatives or analogues, and:

either W is —OH or —O-G S , Y is H and Z is H;

or W is —OH or —O-G S , Y is —OH or —O-G S and Z is H;

or W is —OH or —O-G S , Y is —OH or —O-G S and Z is —OH or —O-G S ;

or W is —OH or —O-G S , Y is H and Z is —OH or —O-G S ;

or W is H, Y is —OH or —O-G S and Z is —OH or —O-G S ;

or W is —OH or —O-G S , Y is alkoxy and Z is H.

6 . The method of claim 11 , wherein the Ginkgo biloba extract comprises from 5.5 to 8% in total of ginkgolides A, B, C and J, from 40 to 60% of flavoneglycosides and from 5 to 7% of bilobalide.

7 . The method of claim 6 , wherein a part at least of the ginkgolides A, B, C and J is replaced with the compounds of the formula

wherein W, X, Y and Z are independently selected from the group consisting of H, OH, alkoxy and —O-G S , G S -OH being a mono- or a disaccharide, or one of their derivatives or analogues,

it being understood that at least one of W, X, Y or Z is —O-G S .

8 . The method of claim 7 , wherein the compounds of formula (I) are such that X is —OH or —O-G S , G S -OH being a mono- or a disaccharide, or one of their derivatives or analogues, and:

either W is —OH or —O-G S , Y is H and Z is H;

or W is —OH or —O-G S , Y is —OH or —O-G S and Z is H;

or W is —OH or —O-G S , Y is —OH or —O-G S and Z is —OH or —O-G S ;

or W is —OH or —OG S , Y is H and Z is —OH or —O-G S ,

or W is H, Y is —OH or —O-G S and Z is —OH or —O-G S ;

or W is —OH or —O-G S , Y is alkoxy and Z is H.

9 . The method of claim 11 wherein the warm-blooded animals are people seeking to lose weight.

10 . The method of claim 11 wherein the warm-blooded animals are people seeking to gain weight.

11 . A method of promoting muscle mass to the detriment of fatty mass in warm-blooded animals comprising administrating to warm-blooded in need thereof an effective amount of a Ginkgo extract comprising at least one member or the group consisting of flavoneglycosides, ginkgolide and ginkgolides to treat weight problems.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME PREVIOUSLY RECORDED ON REEL 296336 FRAME 0777. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 5, 2016
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
To: IPSEN PHARMA S.A.S.
Reel/Frame 037430/0194 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS PREVIOUSLY RECORDED ON REEL 023034 FRAME 0251. ASSIGNOR(S) HEREBY CONFIRMS THE ADDRESS SHOULD BE 65 QUAI GEORGES GORSE, 92100 BOULOGNE-BILLANCOURT, FRANCE. Recorded Jan 16, 2013
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION SCIENTIFIQUES (S.C.R.A.S.)
To: IPSEN PHARMA S.A.S.
Reel/Frame 029636/0777 →
CHANGE OF NAME Recorded Jul 31, 2009
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION SCIENTIFIQUES (S.C.R.A.S.)
To: IPSEN PHARMA S.A.S.
Reel/Frame 023034/0251 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2004
From: CHRISTEN, YVES
To: SOCIETE DE CONSEILS DE RECHERCHES ET APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.)
Reel/Frame 016693/0535 →